# Assessment of New Molecular Imaging Strategies for Prostate Cancer

> **NCT02813226** · NA · COMPLETED · sponsor: **Ontario Clinical Oncology Group (OCOG)** · enrollment: 36 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Molecular Imaging

## Key facts

- **NCT ID:** NCT02813226
- **Lead sponsor:** Ontario Clinical Oncology Group (OCOG)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-16
- **Primary completion:** 2020-03-20
- **Final completion:** 2021-12-17
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02813226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02813226, "Assessment of New Molecular Imaging Strategies for Prostate Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02813226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*